Latest News & Features
Generics
Decision affects a patent listed in the Orange Book | Generic drug makers have so far failed to secure approval for biosimilar versions of the blockbuster drug. 11 July 2023
Americas
John Rearick is the latest addition to the firm to strengthen its life sciences practice. 11 July 2023
Americas
Certain problems with the patent opposition process need to be addressed in order to protect patent owners, say Alejandro Luna and Luz Elena Elias of Olivares. 9 July 2023
Americas
Commission says that medical device maker’s arguments have broad implications for antitrust enforcement | Dispute concerns alleged exclusive-dealing and bundling arrangements. 5 July 2023
Big Pharma
With competition, employee mobility and chatbots all on the rise, protecting IP as trade secrets has never been more important for life sciences firms, says Anthony Fitzpatrick of Duane Morris. 5 July 2023
article
The firm’s presence in Shenzhen will expand its focus on tech industries in the region. 5 July 2023
Big Pharma
Verdict confirms legality of 2014 patent settlement, dismissing allegations of anti competitive practices. 4 July 2023
article
Lewis Silkin has integrated MSK into its practice to better manage complex portfolios across various tech sectors. 4 July 2023
Big Pharma
Board did not violate procedure regarding ‘preliminary guidance’ say Federal Circuit judges | Medytox’s substitute claims found to be ‘unpatentable’. 29 June 2023
Big Pharma
Revocation and infringement actions involving a cholesterol treatment, prosthetic valves, and methods for analyte detection are among the first to land at the court within its first month, explain Joanne Welch and Darren Smyth of EIP. 29 June 2023